Cheryl Maley

Ms Maley has over 25 years of experience in the pharmaceutical industry, including 20 years in senior commercial, executive and leadership roles across Australia, Asia, and international markets. Prior to joining Starpharma, Ms Maley was Acting CEO and Strategic Advisor at Biointelect and previously held senior roles at Novartis, AbbVie/Abbott, Servier Laboratories, and Wyeth Pharmaceuticals, with responsibilities spanning new products, commercialisation, strategy, reimbursement matters, sales, marketing, and general management. Ms Maley has a record in pharmaceutical innovation, product commercialisation, business growth, patient access, and reimbursement. Ms Maley has held a board position at Neuroscience Research Australia (NeuRA), a not for profit medical research institute, since February 2024.